The Relevance Between the Level of Fetal Hemoglobin and Short-term Complications in Extremely Preterm Infants

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05788562

Enrollment

Registered

2023-03-29

Start date

2023-04-01

Completion date

2024-05-30

Last updated

2023-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Hemoglobin

Brief summary

A monocentric prospective study was conducted to find the relevance between the level of fetal hemoglobin and short-term complications in extremely preterm infants

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Days to 2 Months

Healthy volunteers

Inclusion criteria

1. Preterm infants with gestational age \<32 weeks or birth weight \<1500g 2. Parents agree to attend

Exclusion criteria

1. serious functional or organic diseases 2. severe congenital deformity 3. parents reject to attend

Design outcomes

Primary

Measure	Time frame	Description
Occurrence and severity of early complications in premature infants	2022.1-2023.1	include necrotizing enterocolitis,bronchopulmonary dysplasia,retinopathy, Intraventricular hemorrhage above degree Ⅱ,leukomalacia,late-onset sepsis

Countries

China

Contacts

Primary ContactQu Yangming

quym@jlu.edu.cn15844092520

Outcome results